<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pediatr Rheumatol Online J</journal-id><journal-id journal-id-type="iso-abbrev">Pediatr Rheumatol Online J</journal-id><journal-title-group><journal-title>Pediatric Rheumatology Online Journal</journal-title></journal-title-group><issn pub-type="epub">1546-0096</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4184277</article-id><article-id pub-id-type="publisher-id">1546-0096-12-S1-P58</article-id><article-id pub-id-type="doi">10.1186/1546-0096-12-S1-P58</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>The efficacy and cost effectiveness of a multidisciplinary intervention strategy for the treatment of benign joint hypermobility syndrome (BJHS) in childhood. a randomised, single centre parallel group trial. (The bendy study)</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Bale</surname><given-names>Peter J</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Easton</surname><given-names>Vicky</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Bacon</surname><given-names>Holly</given-names></name><xref ref-type="aff" rid="I2">2</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Jerman</surname><given-names>Emma</given-names></name><xref ref-type="aff" rid="I3">3</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Armon</surname><given-names>Kate</given-names></name><xref ref-type="aff" rid="I4">4</xref></contrib></contrib-group><aff id="I1"><label>1</label>Norwich Medical School, University of East Anglia, UK</aff><aff id="I2"><label>2</label>Paediatric Physiotherapy, Norfolk and Norwich University Hospital, UK</aff><aff id="I3"><label>3</label>Occupational therapy, University of East Anglia, UK</aff><aff id="I4"><label>4</label>Jenny Lind Children's Department, Norfolk and Norwich University Hospital, Norwich, UK</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>17</day><month>9</month><year>2014</year></pub-date><volume>12</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">Proceedings of the 21st European Pediatric Rheumatology (PReS) Congress</named-content><named-content content-type="supplement-sponsor">The publication charges for this supplement were funded by the PReS 2014 congress.</named-content></supplement><fpage>P58</fpage><lpage>P58</lpage><permissions><copyright-statement>Copyright &#x000a9; 2014 Bale et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Bale et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.ped-rheum.com/content/12/S1/P58"/><conference><conf-date>17-21 September 2014</conf-date><conf-name>21st European Pediatric Rheumatology (PReS) Congress</conf-name><conf-loc>Belgrade, Serbia</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Joint hypermobility is common in childhood and can be associated with musculoskeletal pain and dysfunction. Current management is delivered by a multidisciplinary team but evidence of efficacy is limited.</p></sec><sec><title>Objectives</title><p>This clinical trial aimed to determine whether a structured multidisciplinary intervention resulted in improved clinical outcomes compared with standard care</p></sec><sec sec-type="methods"><title>Methods</title><p>A prospective randomised, single centre parallel group trial comparing an 8-week individualised multidisciplinary intervention programme with current standard management (advice and a physiotherapy appointment). Children and young people (CYP) were assessed for pain, function, coordination and strength at baseline, 3 and 12 months.</p></sec><sec sec-type="results"><title>Results</title><p>119 CYP, aged 5 to 16 years, with symptomatic hypermobility were randomised to receive targeted multidisciplinary intervention (I) (n=59) or standard management (S) (n=60). Of these, 105 were followed to 12-months. There was a significant improvement in child and parent reported pain, coordination and strength. However, no added benefit could be shown from the intervention (Table <xref ref-type="table" rid="T1">1</xref>). The number of CYP showing significant pain reduction (&#x0003e;=40%) was 27 (50.0%) (I) vs 21 (41.1%) (S). Those pain free at 12 months were 29 (56.9%) (I) vs 20 (45.5%) (S). The response was independent of the degree of hypermobility.</p><table-wrap id="T1" position="float"><label>Table 1</label><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left">Baseline score (SD)</th><th align="center" colspan="4">Rate of change over 12 months (95% CI)</th></tr><tr><th colspan="1"><hr/></th><th align="left"/><th colspan="4"><hr/></th></tr><tr><th align="left">Outcome variable</th><th align="left"/><th align="center" colspan="2">Intervention group</th><th align="center" colspan="2">Control</th></tr></thead><tbody><tr><td align="left">Child pain assessment (0-5, zero is the best), n=103</td><td align="left">2.31 (1.55)</td><td align="center">-1.42</td><td align="center">(-1.78 to -1.06)</td><td align="center">-1.31</td><td align="center">(-1.75 to -0.85)</td></tr><tr><td colspan="6"><hr/></td></tr><tr><td align="left">Parent observed pain assessment (0-100 VAS, zero is the best) n=105</td><td align="left">35.90 (26.46)</td><td align="center">-6.09</td><td align="center">(12.90 to 0.73)</td><td align="center">-6.22</td><td align="center">(-13.62 to 1.18)</td></tr><tr><td colspan="6"><hr/></td></tr><tr><td align="left">Child health assessment questionanire (CHAQ) (0-3, zero is the best), n=104</td><td align="left">0.82 (0.63)</td><td align="center">+0.02</td><td align="center">(-0.12 to 0.16)</td><td align="center">-0.03</td><td align="center">(-0.13 to 0.64)</td></tr><tr><td colspan="6"><hr/></td></tr><tr><td align="left">Child health 9 dimensional utility (CHU9D) (0-1, zero is the worst), n=104</td><td align="left">0.85 (0.11)</td><td align="center">+0.02</td><td align="center">(-0.01 to 0.04)</td><td align="center">+0.002</td><td align="center">(-0.02 to 0.03)</td></tr><tr><td colspan="6"><hr/></td></tr><tr><td align="left">Movement assessment battery for children (M-ABC) (0-100, zero is theworst), n =104</td><td align="left">34.56 (28.61)</td><td align="center">+2.60</td><td align="center">(-2.92 to 8.11)</td><td align="center">+8.51</td><td align="center">(3.17 to 13.86)</td></tr><tr><td colspan="6"><hr/></td></tr><tr><td align="left">Grip Strength (Dynamometer), n=104</td><td align="left">57.29 (28.30)</td><td align="center">+4.55</td><td align="center">(0.16 to 8.94)</td><td align="center">+6.75</td><td align="center">(2.85 to 10.66)</td></tr></tbody></table></table-wrap></sec><sec sec-type="conclusions"><title>Conclusion</title><p>This is the first RCT to compare a structured multidisciplinary intervention with standard care in symptomatic childhood hypermobility. The study demonstrates significant improvement among subjects but no additional benefit from targeted intervention. The findings emphasise the benefit of information and physiotherapy, but highlight the difficulty in demonstrating subtle benefit from specific interventions without better tools for case definition and outcomes assessment.</p></sec><sec><title>Trial registration identifying number</title><p>UKCRN Portfolio 9366.</p></sec><sec><title>Disclosure of interest</title><p>None declared.</p></sec></body></article>